# Virginia National Bankshares Corp: overview VABK · Nasdaq · CIK 1572334 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/vabk.md) · [Financials](/companies/vabk/financials.md) · [Filings](/companies/vabk/filings.md) · [Insiders](/companies/vabk/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.85](/filings/0001193125-25-277706.md) | not reported | [0.83](/filings/0001193125-26-219603.md) | [0.78](/filings/0001193125-26-348243.md) | [0.84](/filings/0001193125-25-277706.md) | not reported | [0.97](/filings/0001193125-26-219603.md) | [1.65](/filings/0001193125-26-348243.md) | | Free cash flow | $m | [15.1 d](/filings/0001193125-25-277706.md) | [3.2 d](/filings/0001193125-26-128416.md) | [1.8](/filings/0001193125-26-219603.md) | [6.7 d](/filings/0001193125-26-348243.md) | [5.9 d](/filings/0001193125-25-277706.md) | [6.2 d](/filings/0001193125-26-128416.md) | [7.0](/filings/0001193125-26-219603.md) | [3.4 d](/filings/0001193125-26-348243.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [2.14](/filings/0000950170-23-010585.md) | [4.38](/filings/0000950170-24-038005.md) | [3.58](/filings/0000950170-25-046927.md) | [3.15](/filings/0001193125-26-128416.md) | [3.55](/filings/0001193125-26-128416.md) | | Free cash flow | $m | [11.8](/filings/0000950170-23-010585.md) | [22.1](/filings/0000950170-24-038005.md) | [12.7](/filings/0000950170-25-046927.md) | [14.6](/filings/0001193125-26-128416.md) | [20.8](/filings/0001193125-26-128416.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/vabk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $14.0m | 314,954 | | Added +29,779 | | [ENDEAVOUR CAPITAL ADVISORS INC](/funds/1218749.md) | 2026-06-30 | $13.3m | 298,750 | | Unchanged | | [Atlantic Union Bankshares Corp](/funds/883948.md) | 2026-06-30 | $10.8m | 242,242 | | Unchanged | | [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $9.2m | 207,431 | | Reduced −1,552 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $9.0m | 202,845 | | Reduced −22,444 | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $7.4m | 193,270 | | Added +140 | | [Meridian Financial Partners LLC](/funds/1763722.md) | 2026-06-30 | $5.8m | 127,161 | | Reduced −10,499 | | [STRATEGIC VALUE BANK PARTNERS LLC](/funds/1904067.md) | 2026-06-30 | $5.7m | 128,953 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $5.6m | 125,976 | | Added +7,952 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.6m | 81,722 | | Added +179 | ## Recent filings [All 489 filings](/companies/vabk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-29 | 16:30 ET | [8-K](/filings/0001193125-26-437868.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-437868 | | 2026-10-08 | 07:30 ET | [8-K](/filings/0001193125-26-417432.md) | 8.01 Other events | 0001193125-26-417432 | | 2026-08-13 | 11:00 ET | [10-Q](/filings/0001193125-26-348243.md) | Quarterly report, period 2026-06-30 | 0001193125-26-348243 | | 2026-07-23 | 16:30 ET | [8-K](/filings/0001193125-26-314197.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-314197 | | 2026-06-29 | 11:45 ET | [8-K](/filings/0001193125-26-287670.md) | 5.07 Shareholder vote results | 0001193125-26-287670 | | 2026-05-15 | 09:00 ET | [8-K](/filings/0001193125-26-225478.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-225478 | | 2026-05-12 | 16:30 ET | [10-Q](/filings/0001193125-26-219603.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219603 | | 2026-05-04 | 16:30 ET | [8-K](/filings/0001193125-26-204095.md) | 8.01 Other events | 0001193125-26-204095 | | 2026-04-30 | 08:00 ET | [DEF 14A](/filings/0001193125-26-194099.md) | Proxy statement, period 2026-06-25 | 0001193125-26-194099 | | 2026-04-23 | 08:45 ET | [8-K](/filings/0001193125-26-171985.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-171985 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-128416.md), filed Mar 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1572334 - Tickers: VABK - Exchange: Nasdaq - SIC code: 6021 National Commercial Banks - State of incorporation: VA - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:28 ET. No prices; not investment advice.